Lose 23% of your body weight in 1 year according to research

Ships free to your door in 2-7 days with tracking

FDA-approved medications for weight loss and diabetes


Common Questions About Zepbound®

Learn more about Zepbound®, how it works and how to get approved.

Zepbound® uses the same active ingredient (tirzepatide) as Mounjaro®. It’s a dual-action GLP-1/GIP that is approved by the FDA for people with obesity BMI ≥30, or overweight BMI ≥27 plus a weight-related condition, along with diet and exercise changes.

Zepbound® and Wegovy® are approved by the FDA for weight loss, while Ozempic® is approved for the treatment of type 2 diabetes, but can be prescribed off-label for weight loss, if appropriate.

The main difference between these medications is the active ingredient. Ozempic® and Wegovy® use semaglutide, while Zepbound® uses tirzepatide. Tirzepatide is a dual-action GLP-1 and GIP, meaning it works by activating two hormone receptors that regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.

Reach out to our team using our website chatbot or e-mail care@oaklovesyou.com for more information!